Pitavatin M Tablets 2 mg (Pitavastatin Calcium)

Adult dose

For adults, the usual initial dose is 1 to 2 mg of pitavastatin calcium, taken once daily. If the LDL cholesterol-lowering effect is insufficient, the dose may be increased to a maximum of 4 mg per day. Dosage should be adjusted appropriately at intervals of 4 weeks or more, based on LDL cholesterol levels, treatment goals, and the patient's response. The therapeutic effect of this medication is maintained with continuous administration.

This drug should not be used in patients with allergies to specific ingredients or with liver disease, bile duct obstruction, or severe hepatic impairment. It should not be administered to patients taking cyclosporine, those with myopathy, women who are pregnant or may become pregnant, nursing mothers, and children. Caution should be exercised in patients with poor kidney function, liver impairment, those who consume alcohol excessively, those with hypothyroidism, muscle-related disorders, or elderly patients. This drug may cause various side effects such as muscle pain, muscle weakness, liver function abnormalities, thrombocytopenia, and skin rashes, so any unusual symptoms should be immediately reported to a healthcare provider. Particularly, if symptoms such as muscle pain, weakness, or changes in urine color occur, it may indicate serious muscle damage known as rhabdomyolysis, and the medication should be stopped immediately and medical attention sought. Since this drug is primarily metabolized in the liver, regular liver function tests should be performed, and the drug should be discontinued if liver enzyme levels rise. There may be interactions with other medications, so caution is necessary, especially when taken with cyclosporine, fibrates, niacin, and erythromycin. For the elderly, adjustments in dosage may be necessary due to decreased bodily functions, making side effects more likely. Pregnant or nursing women should not take this medication, and women who may become pregnant should confirm their pregnancy status before taking it. Safety and efficacy in children have not been established, so it is not used in this population. Keep the medication out of the reach of children, and store it in its original container; transferring to another container increases the risk of misuse or quality degradation. As this medication is used for the treatment of hypercholesterolemia, it is advisable to undergo lipid level testing before administration and to combine it with dietary and exercise therapies. During treatment, lipid levels should be regularly monitored to confirm the effectiveness of the medication; if there is no effect, the treatment should be discontinued.

Serious side effects

Hives, severe swelling (edema), chest tightness, difficulty breathing, cold sweats, pallor, severe rash with fever, blisters, skin peeling, pain in oral/ocular mucosa, shortness of breath or difficulty breathing, asthma attack, respiratory abnormalities with cough and fever, jaundice (yellowing of skin or eyes), extreme lethargy, sudden and severe headache, thunderclap headache, seizures, confusion, visual disturbances, paralysis, urination changes

Mild side effects

• Abdominal pain
• rash
• fatigue
• paralysis
• itching
• stiffness
• drowsiness
• insomnia
• headache
• heaviness in the head

This medication is sensitive to light, so it should be stored in a container that does not allow light to pass through. Additionally, the drug should be kept at normal room temperature, avoiding extremely hot or cold places, preferably between 1 and 30 degrees Celsius.

Appearance

Very light yellow-red round film-coated tablet with a score line

Package unit

30 tablets/bottle, 100 tablets/bottle